The Goofus and Gallant of Diabetes

Who do you relate to more when it comes to diabetes management? An angel who follows the recommended guidelines (Jeremy/Gallant), or a stubborn hellion easily influenced by temptation (Steve/Goofus)? Check out some of these scenarios from Dr. E. and see if you are who you think you are.

read more

Evaluating Type 2 Meds, Part 5: SGLT-2 (Sodium-Glucose Co-Transporter 2) Inhibitors

SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.

read more